Pioglitazone is a highly selective synthetic agonist of the nuclear transcription factor peroxisome proliferation-activated receptor gamma (PPAR-γ), which is widely used as an insulin sensitizer in type 2 diabetes. This evidence concerns the gene PPARG and type 2 diabetes mellitus.